
Academic Journal
Q1Veterinary and Comparative Oncology
About Veterinary and Comparative Oncology
Veterinary and Comparative Oncology is a scholarly journal published by Wiley-Blackwell Publishing Ltd. SCImago 2025 lists it in Q1, with an SJR of 0.627 and H-index of 56.
Coverage: 2007-2026. Research categories: Veterinary (miscellaneous) (Q1).
Verified field sources
- Editor(s): Douglas H. Thamm (Editor in Chief); Floryne Buishand and Laura Selmic (Associate Editors) (Editor) — Official source; checked 2026-10-03. Editorial leadership listed under Edited By on the Wiley journal homepage; publisher role retained without assuming Editor-in-Chief.
- Journal Impact Factor: 1.8 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
Source-backed journal facts
Topics in published research
Veterinary Oncology Research; Infectious Diseases and Mycology; Virus-based gene therapy research; Oral and Maxillofacial Pathology; Microbial infections and disease research; Cancer Research and Treatments.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,730.00 USD; 3,940.00 EUR; 3,210.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Comparison of an Anti‐α v β 3 Integrin NIR Fluorescent Probe and Indocyanin Green for Precision Resection of Naturally Occurring Sarcomas in Dogs—A Randomized Blinded Case‐Controlled Pilot Study
Mirja Christine Nolff, Paula Grest, Frauke Seehusen, Patricia Beer et al.
2026-10-02 · DOI: 10.1111/vco.70116Pathologic Characterization and Clinical Significance of Lymphovascular Invasion in Canine Thyroid Carcinomas
Maureen A. Griffin, Brianna Stoyle, Allie Oakes, Brian Flesner et al.
2026-09-24 · DOI: 10.1111/vco.70118Tolerability and Outcome of Medical Treatment in Feline Nasal Carcinomas: A Multi‐Institutional Retrospective Study
Filomena Amato, Matteo Gobbetti, Antonio Giuliano, Elisabetta Treggiari et al.
2026-09-24 · DOI: 10.1111/vco.70117Precision‐Guided Therapy for Canine Cancers: An Oasis or a Mirage?
Jaime F. Modiano
2026-09-24 · DOI: 10.1111/vco.70119Retrospective Comparison of Gastrointestinal Toxicity in Dogs With Lymphoma Receiving Doxorubicin With or Without Prophylactic Trimethoprim‐Sulfadiazine
Emily Jayne Madden, Catherine Chan
2026-09-21 · DOI: 10.1111/vco.70113Perceptions of Veterinary Radiation Therapy Adverse Events Among Allied Specialists
Juneshine Park, Nicholas Rancilio, Meredith t'Hoen, Rebecca Walton et al.
2026-09-15 · DOI: 10.1111/vco.70114Comparative Phenotypic and Molecular Characterisation of Feline Oral Squamous Cell Carcinoma Cell Lines Reveals Marked Biological Heterogeneity
Qaisar Tanveer, Lisa Y. Pang, Colin Farquharson, Gurå Therese Bergkvist et al.
2026-09-13 · DOI: 10.1111/vco.70115Assessment of Clinical and Immunological Factors of Local Recurrence in Canine Soft Tissue Sarcoma
Kazuki Mizuta, Helene Philibert, Arata Matsuyama
2026-09-09 · DOI: 10.1111/vco.70111Feline Mammary Carcinomas: Clinical Perspectives on Diagnosis, Staging, Treatment and Prognosis
Gonçalo N. Petrucci, Luís Lobo, Felisbina Pereira Queiroga
2026-09-07 · DOI: 10.1111/vco.70109Quality of Life Shapes Owner Decision‐Making in Canine Cancer Care: Insights From Large‐Scale Online Discourse
Georgina Anne Tarrant, Andi Flory, Taranpreet Singh Rai, Andrea Wright et al.
2026-09-06 · DOI: 10.1111/vco.70112Author Index
2026-09 · DOI: 10.1111/vco.70099Abstracts From 2026 Annual Conference
2026-09 · DOI: 10.1111/vco.70098Author Index
2026-09 · DOI: 10.1111/vco.70096ESVONC Congress 2026_Abstracts
2026-09 · DOI: 10.1111/vco.70095Combination of Hypofractionated Radiation Therapy and Gilvetmab for the Treatment of Cutaneous or Subcutaneous Mast Cell Tumours in Dogs
Tiffany W. Martin, Douglas H. Thamm, Kristen M. Weishaar
2026-09-01 · DOI: 10.1111/vco.70110Issue Information
2026-09 · DOI: 10.1111/vco.70094Issue Information
2026-09 · DOI: 10.1111/vco.70100Reviews
Community Reviews
Version History
October 4, 2026 at 9:12 pm
October 2, 2026